Genes within the class II region of the major histocompatibility complex (MHC), including genes involved in antigen processing and presentation, have been reported to be associated with several autoimmune diseases. We report here that the LMP/TAP gene region is significantly associated with vitiligo, a disorder in which biochemical defects and/or autoimmune destruction cause melanocyte loss and resulting skin depigmentation. Case/control analyses revealed genetic association of vitiligo in Caucasian patients with an early age of onset with the transporter associated with antigen processing-1 (TAP1) gene. A familybased association method revealed biased transmission of specific alleles from heterozygous parents to affected offspring for the TAP1 gene, as well as for the closely linked LMP2 and LMP7 genes encoding subunits of the immunoproteasome. No association with vitiligo was found for the MECL1 gene, which encodes a third immunoproteasome subunit and is unlinked to the MHC class II region. These results suggest a possible role for the MHC class I antigen processing and/or presentation pathway in the antimelanocyte autoimmune response involved in vitiligo pathogenesis.
Introduction
The major histocompatibility complex (MHC) class II genomic region of the human HLA locus has been very important in the study of the genetics of autoimmunity, as statistically significant associations have been reported between many of the gene polymorphisms in this region and human autoimmune diseases. This highly polymorphic region includes several genes involved in the processing and presentation of antigen to the immune system, including low molecular weight polypeptide-2 and -7 (LMP2 and LMP7) and transporter associated with antigen processing protein-1 and -2 (TAP1 and TAP2). These four genes are associated with several autoimmune diseases, such as type I diabetes, juvenile rheumatoid arthritis, ankylosing spondylitis, celiac disease, Sjö gren's syndrome and multiple sclerosis. [1] [2] [3] [4] [5] [6] LMP2 and LMP7 encode IFN-g inducible subunits of the immunoproteasome, which degrade ubiquitintagged cytoplasmic proteins into peptides that are especially suited for presentation by MHC class I molecules. 7, 8 An additional IFN-g inducible subunit, multicatalytic endopeptidase complex-like-1 (MECL1), is part of the immunoproteasome complex, but is encoded on a different chromosome than the MHC region. TAP1 and TAP2 encode subunits of an IFN-g inducible heterodimer that binds peptides in the cytoplasm and transports them into the endoplasmic reticulum where they can be loaded into nascent MHC class I molecules. 8 Many HLA associations have been reported between specific alleles of complement, class I and class II MHC genes with vitiligo (reviewed in Friedmann 9 ), and recent segregation and linkage disequilibrium analyses of microsatellite markers spanning the entire HLA region suggested a major HLA genetic factor segregating as a dominant factor in patients with early onset of vitiligo. 10 Vitiligo is a common dermatological disorder of the epidermis and hair follicles, affecting both genders and B1% of the population in all ethnic groups worldwide, and manifested clinically as expanding hypopigmented lesions of the skin. 11 Although the etiology of vitiligo is largely unknown, immunohistochemical and melanocyte culture studies suggest that depigmentation is due to the loss of most melanocytes from vitiligo lesions, rather than melanocyte inactivation or dormancy. 12, 13 Two principal hypotheses concerning the etiology of vitiligo include: (1) the self-destruct model, which suggests that biochemical and/or structural defects inherent to patient melanocytes contribute to the initiation and/or progression of melanocyte cytolysis; and (2) the autoimmune model, which suggests that melanocyte death occurs through inappropriate immune system destruction of pigment cells. 11, 14 There is considerable evidence that disease progression in some vitiligo patients involves autoimmune attack of the melanocytes, as evidenced by the presence of both cellular [15] [16] [17] and humoral [18] [19] [20] antimelanocyte autoimmune responses.
The importance of genetic factors in vitiligo susceptibility has been suggested by reports of significant familial aggregation. For example, about 20% of vitiligo patients have at least one first-degree relative also affected, and the relative risk of vitiligo for first-degree relatives of vitiligo patients is increased by at least sevento 10-fold. 21, 22 Vitiligo susceptibility does not follow a simple Mendelian inheritance pattern, and much of the available data support the hypothesis that vitiligo is a complex hereditary disease influenced by a set of recessive alleles occurring at several unlinked autosomal loci that collectively confer the vitiligo phenotype. [22] [23] [24] Vitiligo may therefore be considered a polygenic disease, with alleles at multiple loci possibly contributing to increased susceptibility to and/or direct pathogenesis of vitiligo. We have recently reported association of the catalase gene and vitiligo susceptibility in support of the self-destruct model of vitiligo pathogenesis. 25 We report here case-control and family-based genetic association studies for the TAP1, TAP2, LMP7, LMP2 and MECL1 genes in human vitiligo patients. The LMP/TAP gene region was found to be significantly associated with vitiligo in Caucasian patients, suggesting a possible role for MHC class I antigen processing and/or presentation in the antimelanocyte autoimmune response involved in vitiligo pathogenesis.
Results
Case/control association studies Allele and genotype frequencies. The single-nucleotide polymorphisms (SNPs) used in this study as genetic markers for the LMP/TAP genes and MECL1 are listed in Table 1 . Preliminary case/control analyses of a patient population consisting 230 unrelated Caucasian vitiligo patients and 188 unrelated Caucasian controls revealed significant differences in allele and/or genotype frequencies, suggesting association with the candidate genes TAP1 and TAP2 (data not shown). However, when the existence of population heterogeneity among the case and control sets was tested by using Wright's F statistic according to the unbiased methods (y value) of Weir and Cockerham, 26 a significant difference between the case and control populations was indicated. The vitiligo patient population was therefore stratified by age of onset as suggested by Arcos-Burgos et al, 10 whose segregation and linkage disequilibrium analyses of the HLA region revealed a dominant genetic factor segregating in vitiligo patients with an early age of onset (0-29 years).
There was no significant difference in population structure between a case population consisting of 100 Caucasian patients with an age of vitiligo onset of 0-29 years and the control set as defined by subdivision analysis, which showed that the y value was not significantly different than zero (y ¼ 0.0050, 95% confidence interval À0.0010 to 0.0116). Exact tests for the Hardy-Weinberg equilibrium and linkage disequilibrium are shown in Table 2 . Deviation from HardyWeinberg equilibrium was observed for the TAP2 A/G exon 5 genetic marker in both the patient and control populations. After Bonferroni's correction for multiple comparisons, significant linkage disequilibrium was observed between LMP2-TAP1, LMP2-LMP7 and TAP1-LMP7 genetic markers in patients, and between LMP2-TAP1, LMP2-LMP7, LMP2-TAP2, TAP1-LMP7, LMP7-LMP7 and LMP7-TAP2 genetic markers in controls ( Table 2) . Underlined nucleotide in primer TAP1-16 was changed from the germline G to a C to create the MspI RFLP. Underlined nucleotide in primer LMP7-Z was changed from the germline A to a C to create the PstI RFLP. c Underlined nucleotide in primer TAP2-3 was changed from the germline T to a G to create the BstUI RFLP.
The allele and genotype frequencies for the seven LMP/ TAP and one MECL1 genetic markers genotyped for 100 Caucasian vitiligo patients with early age of onset (0-29 years) and 188 unrelated Caucasian control subjects are shown in Tables 3 and 4 , respectively. No significant differences were observed for the allele counts and frequencies of six of the eight markers examined ( Table  3 ). The G/T SNP in intron 6 of the LMP7 gene displayed an excess of the G allele in the patient vs control groups (P ¼ 0.040). The G/A SNP in exon 10 of the TAP1 gene (D637G) exhibited a significant excess of the G allele in the patient vs control groups (P ¼ 0.0034). Table 4 lists genotype counts and percentages for 100 Caucasian vitiligo patients with early age of onset and 188 unrelated controls, as well as the P-values determined by w 2 analysis of 3 Â 2 contingency tables. No significant differences were observed for seven of the eight markers genotyped. The G/A SNP in exon 10 of the TAP1 gene (D637G) exhibited a significant excess (P ¼ 0.0094) of the GG genotype allele in vitiligo patients (71.4%) compared to controls (53.4%). Furthermore, comparison of the individual allele carriage rates for this marker confirmed that the A allele carriage rate is significantly lower in patients than in controls (28.6 vs 46.6%, P c ¼ 0.0073), and that the overall G carriage rate is higher in patients than in controls, although not statistically significant (99.0 vs 95.4%, P c ¼ 0.22). Taken together, these results suggest a possible association between the TAP1 gene in the LMP/TAP gene cluster and vitiligo susceptibility. 
Family-based association
Further evidence for genetic association between LMP/ TAP genes and vitiligo susceptibility was sought using the transmission disequilibrium test (TDT), a familybased (intrafamilial) study design that considers heterozygous parents and evaluates the frequency with which alleles are transmitted to affected offspring. 27 A w 2 test was used to evaluate the deviation of the rates of transmission and nontransmission from the random expectation (Table 5 ). For the TAP1 G/A exon 10 (D637G) marker, only 35 informative (heterozygous) parents could be identified. Although the number of informative parents is relatively low, analysis of this marker suggests unequal transmission of alleles to affected children, with the G allele being transmitted more frequently (69%) than expected due to random chance (P ¼ 0.028), which is consistent with the allele and genotype frequencies described above.
Interestingly, TDT analysis of the other genes in the LMP/TAP cluster revealed additional evidence for biased transmission of LMP/TAP alleles in vitiligo patients, with significant differences detected (Po0.05) for LMP2, TAP1 and LMP7 genetic markers. Similar to the results for the TAP1 G/A exon 10 marker, the LMP2 G/A exon 3 (R60H) and TAP1 C/T intron 7 markers displayed allele transmission frequencies of 68%, and TDT P-values of 0.023 and 0.011, respectively. The most highly significant TDT result (Po0.00006) was observed for the LMP7 G/T intron 6 marker, for which there were 45 informative parents available. The G allele was transmitted from unaffected parents to affected children much more often (80%) than expected due to random chance.
Discussion
Through the use of a candidate gene approach, we report evidence for genetic association between vitiligo and the LMP/TAP region. Case/control analyses reveal association of vitiligo and the gene encoding TAP1, whereas a family-based association method (TDT) revealed biased transmission of specific alleles from heterozygous parents to affected offspring for the TAP1 gene, as well as for the LMP2 and LMP7 genes. No association with vitiligo was found for the MECL1 gene, which encodes a third immunoproteasome subunit and is unlinked to the MHC class II region.
Two other recent reports have also implicated the MHC class II region in vitiligo susceptibility. Using a whole genome scan of a large family cluster with both vitiligo and Hashimoto thyroiditis, a general autoimmune susceptibility locus (AIS1) was mapped to human chromosome 1, and evidence was reported for a Hashimoto disease susceptibility locus within a chromosome 6 region spanning both the MHC and AIDT1, a non-MHC locus associated with susceptibility to both Hashimoto thyroiditis and Graves' disease. 24 A linkage disequilibrium analysis of 56 multigeneration Columbian families with vitiligo using microsatellite markers spanning the entire human MHC region revealed a major genetic factor within the MHC at 6p21.3-21.4, with a dominant mode of inheritance in vitiligo patients with an early age of onset and a recessive mode of inheritance influenced by environmental effects in vitiligo patients with an age of onset after 30 years of age. 10 Comparisons of a variety of inheritance models suggested that the most parsimonious genetic model was that of a major Many other HLA associations have been reported between specific alleles of complement, class I and class II MHC genes with vitiligo in various ethnic and racial subpopulations (reviewed in Friedmann 9 ), but no common HLA association is observed. Insufficient numbers of vitiligo patients from other ethnic and racial populations were available for comparison to Caucasians in this study. Several studies have reported HLA associations in early-onset vs late-onset vitiligo cases. 10, 28, 29 Classification of vitiligo patients by age of onset was therefore important to detect valid genetic association with the LMP/TAP gene cluster. We detected no association between the LMP/TAP or MECL1 genes and late-onset vitiligo (data not shown).
We interpret this association study in the LMP/TAP region with caution, given the complications caused by a high occurrence of linkage disequilibrium in the region, for which there are variable and inconsistent reports for markers spanning the entire region from DM and DPB, through the LMP/TAP cluster, and extending to the DRB1, DQA1 and DQB1 genes. [30] [31] [32] Similarly, after Bonferroni's correction, significant disequilibrium values were observed among some, but not all possible pairwise LMP/TAP comparisons within the vitiligo patient and control populations ( Table 2 ). The LMP/TAP gene cluster also features a well-characterized recombination hot spot within intron 2 of the TAP2 gene, 33, 34 and additional recombination hot spots are located throughout the human MHC locus. 35 Until functional data are found to confirm associations with autoimmune disease suggested by genetic studies, definitive conclusions about genetic association in this region will remain controversial, as associations with autoimmune disease may be due to linkage disequilibrium with other genes in the MHC class II region. It has also been suggested that the action of several MHC genes, including the LMP/TAP genes, might contribute to autoimmune disease pathogenesis, and that statistical analyses might average the linkage of the various genes and identify only polymorphic genes located centrally in the MHC class II region. 36 Given these limitations, our data are consistent with genetic association of the LMP/TAP region with vitiligo susceptibility. The LMP/TAP genes play important roles in the regulation of MHC class I antigen processing and presentation. Foreign and self-peptides are processed in the cytoplasm by degradation in the proteasome, a large barrel-shaped threonine protease consisting of four stacked heptameric rings in an a7b7b7a7 conformation. The proteasome usually consists of at least 14 different subunits, three of which have catalytic sites. 37 Upon IFNg stimulation, the constitutive catalytic subunits b5, B2 and b1 are replaced with three IFN-g-inducible subunits, LMP2 (b1i), LMP7 (b5i) and MECL1 (b2i), creating the immunoproteasome. The different patterns of peptide cleavage by the immunoproteasome produce peptides that are more efficiently transported by the TAP complex and have improved binding to the antigen-binding cleft of MHC class I molecules. 7, 8 Peptide transport across the endoplasmic reticulum membrane is directed by the TAP complex, an IFN-g-inducible, ATP-dependent heterodimer consisting of two subunits, TAP1 and TAP2, both of which must be present for peptide binding and translocation. 8 The TAP complex appears to preferentially bind and transport peptides that are better suited for the MHC class I binding grove, that is, peptides that are 8-10 amino acids in length, with basic or hydrophobic C-termini. 38, 39 With the majority of the proteins degraded by the proteasome being self-proteins, the generation of altered forms of antigen by the immunoproteasome and the preferential transport of MHC class I-compatible antigens by TAP are extremely important in influencing the expression of foreign peptide over self-peptide. Thus, it is possible that changes in function and/or expression patterns of TAP or LMP proteins could influence the peptide repertoire expressed to circulating lymphocytes, and allow for the induction of inappropriate immune events to cryptic epitopes of self-peptides for which the immune system has not been made tolerant. TAP1 amino-acid polymorphisms, including D637G (in this report) and I333V, have been reported to influence the permissiveness of transport of specific peptides across the endoplasmic reticulum in some models, 40 and the TAP2 polymorphism T665A (in this report) has been suggested to influence the antibody response to measles virus vaccine. 41 Two functional studies of human TAP polymorphisms, however, revealed no significant influence of human TAP1 or TAP2 alleles on peptide binding and translocation. 42, 43 Fewer functional studies have been performed on LMP polymorphisms; however, it has been reported that the LMP2 R60H and LMP7 Q49K polymorphisms (in this report) affect age-dependent TNF-a apoptosis and response to interferon in patients with chronic hepatitis C, respectively. 44, 45 Immunoproteasomes might also play an integral role in maintaining peripheral tolerance. Immunoproteasomes are constitutively expressed in the thymus and by mature dendritic cells under conditions in which most T-cell activation occurs, whereas elsewhere in the periphery constitutive proteasomes are expressed in the absence of inflammation. Because nonprofessional antigen presenting cells in noninflamed tissue should only present antigens processed by the constitutive proteasome in their MHC class I molecules, T cells specific for these peptides may become anergized upon presentation, due to the lack of costimulation. T cells that become inadvertently activated by self-peptide at a site of inflammation may 'avoid' antigen from the same selfpeptide in noninflamed sites due to differing epitopes produced by the constitutive proteasome. 46 In vitiligo patients, biochemical defects in the melanin pathway that promote oxidative damage could be a trigger for excessive inflammation in the skin. Inappropriate expression or function of either the constitutive proteasome or immunoproteasome might influence antigen processing and presentation, leading to a break in peripheral tolerance to melanocyte self-antigens.
In summary, we have found evidence for genetic association between the LMP/TAP gene cluster and vitiligo susceptibility. Changes in LMP and TAP expression and/or function might influence the peptide repertoire presented by vitiligo patient antigen-presenting cells, by affecting antigen processing by the immunoproteasome or by preferential transport of peptides for MHC class I presentation. Future studies of immunoproteasome and TAP expression and function in vitiligo patient antigen-presenting cells are needed to further define a role for these genes in vitiligo susceptibility.
Materials and methods

Patient and control populations
Blood samples were obtained from vitiligo patients and family members with informed consent according to University of Florida Institutional Review Board guidelines. All patient samples used for case-control and family-based association were from Caucasian subjects with nonsegmental vitiligo living in the United States or Canada. The mean age of onset of vitiligo was 21 years of age (range 0-69). Control samples were from unrelated Caucasian subjects living in the southeastern United States. Control subjects had no known medical history of vitiligo or other autoimmunity, and were beyond the average age of onset for vitiligo (421 years of age).
PCR amplification and genotyping
High molecular weight genomic DNA samples were prepared from white blood cells isolated from whole blood after red blood cell lysis using ammonium chloride, and phenol/chloroform extraction. PCR amplifications were performed using 20 ng of genomic DNA in a 25 ml reaction volume containing 50 mM KCl, 10 mM Tris-Cl, pH 8.3, 1.5 mM MgCl 2 , and 60 mM of each dNTP, and 0.36 U of Taq polymerase (Boehringer Mannheim). Samples were subjected to 35 cycles of 30 s denaturing at 941C, 30 s annealing, and 30 s extension at 721C, followed by a 2 min final extension, using a PTC-100 thermal cycler (MJ Research). PCR primers and annealing temperatures used in this study are listed in Table 1 .
Genotypes were determined by restriction fragment length polymorphism (RFLP) analysis of the PCR products. Following overnight restriction digestion of PCR products under conditions specified by the enzyme supplier (New England Biolabs), restriction fragments were separated by agarose gel electrophoresis in TBE buffer. Genotypes were scored independently by two observers and repeated for ambiguous samples.
SNP markers
The LMP/TAP genes are closely clustered in a 35 kb interval within the MHC class II region. A bidirectional promoter drives LMP2 and TAP1 expression, with LMP2 situated in an opposite transcriptional orientation in relation to the other three genes of the cluster. 47 PCR primer sequences, PCR amplification conditions and restriction fragment sizes are listed in Table 1 .
The single LMP2 SNP genotyped in this study was a G/A substitution, which creates a nonsynonymous amino-acid change (R60H) in exon 3. This SNP was genotyped by RFLP analysis of PCR products using the restriction endonuclease HhaI, which cleaves the G allele, but not the A allele. 1 The first SNP marker in TAP1 was a G/A substitution in exon 10, which creates a nonsynonymous amino-acid change (D637G) and was genotyped using the AccI restriction endonuclease. The A allele is cleaved by AccI, whereas the G allele remains uncut. The second TAP1 marker was a C/T substitution in intron 7, which was genotyped using a modified PCR primer to create an MspI RFLP, such that the C allele is cut and the T allele remains uncut.
The LMP7 GAT intron 6 SNP 1 was genotyped using HhaI, which cleaves the G allele, but not the T allele. The second LMP7 marker genotyped in this study was an A/C substitution in exon 2, which creates a nonsynonymous amino-acid change in codon 49 (Q-K). This SNP marker was genotyped using a modified PCR primer to create a PstI RFLP, such that the C allele is cleaved, whereas the A allele remains uncut.
The first of two TAP2 polymorphisms studied was a G/A substitution resulting in an amino-acid change in exon 5 (V379I). A BstUI RFLP assay was performed using a modified forward primer, such that the G allele is cut by BstUI, whereas the A allele is not. The second TAP2 polymorphism genotyped in this was an A/G substitution resulting in an amino-acid change in exon 11 (T665A). A modified PCR primer created an MspI site such that the G allele is digested by MspI, whereas the A allele remains intact.
The single MECL1 marker, a silent T/C substitution in exon 4 (L107L), was genotyped with MluI, which cleaves the T allele but not the C allele.
Statistical analyses
For case/control association studies, the significance of observed differences in allelic or genotypic frequencies between vitiligo patient and control populations was determined using standard w 2 tests. 48 Allele carriage rates (the percentage of individuals carrying at least one copy) were also compared. A family-based association test, the TDT, was used to confirm genetic associations, using the w 2 td statistic. 27 The existence of population subdivision among the case and control sets was tested using the Wright's F statistic according to the unbiased methods (y value) of Weir and Cockerham. 26 Bootstrap tests (1000 replicates) were performed to determine 95% confidence intervals. Wright's F statistics and Fisher's exact tests for Hardy-Weinberg equilibrium and linkage disequilibrium (pairwise tests) were calculated using the Genetic Data Analysis (GDA) program. 49 Genotypes were preserved in pairwise comparisons for linkage disequilibrium to prevent within locus disequilibrium from affecting significance of disequilibrium in pairwise comparisons.
